Biomaterial Database

[Acute leukemia, leukemoid reaction and leukocytosis after their treatment with oxyphenbutazone]. 1966

D Perers, and S G Sjöberg

UI	MeSH Term	Description	Entries
D007938	Leukemia	A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007955	Leukemoid Reaction	A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed)	Leukemoid Reactions,Reaction, Leukemoid,Reactions, Leukemoid
D007964	Leukocytosis	A transient increase in the number of leukocytes in a body fluid.	Pleocytosis,Leukocytoses,Pleocytoses
D010113	Oxyphenbutazone	A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)	Hydroxyphenylbutazone,Diflamil,Oxyphenylbutazone,Tanderil
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man